Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

kaleo Inc.

www.kaleopharma.com

Latest From kaleo Inc.

Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price

Nonprofit Harm Reduction Therapeutics targets an OTC switch of naloxone, an opioid antagonist used to reverse an opioid overdose. It aims to make the product available at low cost in 110,000 retail locations nationwide.

Consumer Prescription To Otc Switch

Pipeline Watch: Phase III Progress With Tecentriq, Viaskin Peanut And Capalizumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Mylan Communications With CMS To Get Outside Review Under EpiPen Settlement

Corporate integrity agreement requires Mylan to have an independent body review its drug classifications and US best price determinations; settlement resolves claims Mylan misclassified EpiPen to underpay rebates. Sanofi acted as whistleblower in case.

Reimbursement Compliance

Keeping Track: Zelboraf Takes Breakthrough Path For Rare Blood Disease; Teva Resubmits Generic EpiPen

The latest drug development news and highlights from our US FDA Performance Tracker.

Approvals Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Intelliject Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • kaleo Inc.
  • Senior Management
  • T. Spencer Williamson, IV, Pres. & CEO
    Christopher T Schools, CFO
    Kristopher D Ford, VP, Bus. Dev.
    Eric Edwards, MD, PhD, VP, R&D & CMO
  • Contact Info
  • kaleo Inc.
    Phone: (804) 545-6360
    111 Virginia St.
    Ste. 405
    Richmond, VA 23219
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register